Next generation FVIII mimetic bispecific antibody for hemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Next generation FVIII mimetic bispecific antibody for hemophilia A

Published:2022-06 Issue:6 Volume:20 Page:1301-1305
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Voorberg Jan^ORCID,Postmus Tim^ORCID,Schols Saskia^ORCID

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15705

Reference18 articles.

1. The changing treatment landscape in haemophilia: from standard half‐life clotting factor concentrates to gene editing;Mancuso;Lancet,2021

2. BIVV001 fusion protein as factor VIII replacement therapy for hemophilia A;Konkle;N Engl J Med,2020

3. New therapies for hemophilia;Weyand;Blood,2019

4. Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding;Hoffman;Blood Adv,2021

5. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model;Kitazawa;Nat Med,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophilia treatment innovation: 50 years of progress and more to come;Journal of Thrombosis and Haemostasis;2023-03

2. A Review of Factor VIII and Factor IX Assay Methods for Monitoring Extended Half-Life Products in Hemophilia A and B;Methods in Molecular Biology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3